Evaluating Patients With Abnormal Levels of Gastric Acid - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Evaluating Patients With Abnormal Levels of Gastric Acid

This study has been completed.

Study NCT00001240. Last updated on March 4, 2008. Information provided by National Institutes of Health Clinical Center (CC)

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields
Brief Title ^†	Evaluating Patients With Abnormal Levels of Gastric Acid
Official Title ^†	Diagnostic Evaluation of Patients With Suspected Abnormalities of Gastric Secretion
Brief Summary	This study is used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities in the secretion of gastric acid. The level of gastric acid is measured by analyzing the gastric juices of each individual patient. The gastric acid sample is obtained by a procedure known as nasogastric suctioning, where a thin plastic tube is passed from the nose to the stomach. Depending on the patient's present condition further diagnostic testing may be required to achieve a diagnosis.
Detailed Description	This study is an omnibus protocol used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities of gastric acid secretion. Gastric acid secretion is measured by means of analysis of gastric juices obtained by nasogastric suction. Other clinically indicated diagnostic procedures are performed depending on the patient's clinical state in order to reach a diagnosis.
Study Phase
Study Type ^†	Observational
Study Design ^†
Primary Outcome Measure ^†
Secondary Outcome Measure ^†
Condition ^†	Achlorhydria Gastrinoma Zollinger Ellison Syndrome
Intervention ^†
MEDLINE PMIDs	3972233, 2857672, 2877575
Links

Recruitment Information Fields
Recruitment Status ^†	Completed
Enrollment ^†
Start Date ^†	January 1989
Completion Date	January 2004
Eligibility Criteria ^†	Eligibility criteria not identified in the protocol.
Gender	Both
Ages
Accepts Healthy Volunteers	No
Contacts ^††
Location Countries ^†	United States

Administrative Information Fields
NCT ID ^†	NCT00001240
Organization ID	890005
Secondary IDs ^††	89-DK-0005
Study Sponsor ^†	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators ^††
Investigators ^†
Information Provided By	National Institutes of Health Clinical Center (CC)
Verification Date	January 2004
First Received Date ^†	November 3, 1999
Last Updated Date	March 4, 2008

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.